Dr. Daniel C. Rausch, MD
Hematology & Oncology (Hematology & Oncology Physician)
11 Rock Row Ste 120
Westbrook, ME 04092
Who else practices at this address →
Cumberland County includes primary care (5% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Tufts University School of Medicine (2004)
- Years since graduation
- 22
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 224
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2004Medical school: Tufts University School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
ME license 018315 · NH license 23618
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Central Maine Medical Center Lewiston, ME
- St Mary's Regional Medical Center Lewiston, ME
- Mainehealth Franklin Hospital Farmington, ME
- Bridgton Hospital Bridgton, ME
- Rumford Hospital Rumford, ME
Medical groups
- Central Maine Medical Center (342 clinicians)
- Maine Center for Cancer Medicine and Blood Disorders PA (70 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 224
- Services billed
- 626
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Injection, ferric carboxymaltose, 1 mg | 37,500 | 34 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 14,700 | 16 |
| Injection, pembrolizumab, 1 mg | 6,000 | 14 |
| Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,250 | 15 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,210 | 13 |
| Injection, dexamethasone sodium phosphate, 1 mg | 733 | 42 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 409 | 196 |
| Insertion of needle into vein for collection of blood sample | 349 | 175 |
| Injection, granisetron hydrochloride, 100 mcg | 320 | 19 |
| Injection, palonosetron hcl, 25 mcg | 290 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ondansetron Odt (ondansetron) Other prescribers in Westbrook, ME | 118 |
| Prochlorperazine Maleate Other prescribers in Westbrook, ME | 112 |
| Anastrozole Other prescribers in Westbrook, ME | 83 |
| Acyclovir Other prescribers in Westbrook, ME | 52 |
| Dexamethasone Other prescribers in Westbrook, ME | 51 |
| Oxycodone Hcl Other prescribers in Westbrook, ME | 47 |
| Prednisone Other prescribers in Westbrook, ME | 45 |
| Eliquis (apixaban) Other prescribers in Westbrook, ME | 44 |
| Hydroxyurea Other prescribers in Westbrook, ME | 38 |
| Morphine Sulfate Er (morphine sulfate) Other prescribers in Westbrook, ME | 37 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 22 companies reported 53 payments worth $4,953 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $2,276 |
|---|---|
| Pfizer Inc. | $1,723 |
| Pharmacosmos Therapeutics Inc. | $233 |
| AbbVie Inc. | $108 |
| Janssen Biotech, Inc. | $71.97 |
| Array Biopharma Inc | $58.23 |
| Genentech USA, Inc. | $53.39 |
| Progenics Pharmaceuticals, Inc. | $51.47 |
| Consulting Fee | $3,660 |
|---|---|
| Food and Beverage | $1,293 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Oct 19, 2025 | Consulting Fee | $2,010 |
| Pfizer Inc. Nov 20, 2025 | Consulting Fee LORBRENA · ONCOLOGY | $1,375 |
| Pfizer Inc. Dec 15, 2025 | Consulting Fee LORBRENA · ONCOLOGY | $275 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.